Eosinophils depletion therapy for severe asthma management following favorable response to mepolizumab

We described three severe asthmatics whose asthma symptoms were rapidly improved by benralizumab following favorable response to mepolizumab. Benralizumab-induced eosinophil depletion contributed to clinical improvement of severe asthma after mepolizumab-induced eosinophil reduction; thus, prior fav...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsuno, Osamu, Minamoto, Seijiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6630060/
https://www.ncbi.nlm.nih.gov/pubmed/31341763
http://dx.doi.org/10.1016/j.rmcr.2019.100899

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6630060/
https://www.ncbi.nlm.nih.gov/pubmed/31341763
http://dx.doi.org/10.1016/j.rmcr.2019.100899

Ejemplares similares